Fuyang Fifth People's Hospital
Anhui, China
NCT Number: NCT04442477
This is a follow-up study of a multi-center, double-blind, randomized, controlled, parallel-designed, prospective trial and is intended to evaluate neurodevelopment at 5.5 years of age and health outcomes through 5.5 years of age in participants who received one of two staged study formulas through one year of age.
Looking for future studies?
Notify Me64 month–68 month
All sexes
Observational
Anhui, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Enriched protein fractions
Protein fractions
Time frame: At 5.5 years of age
Time frame: At 5.5 years of age
Time frame: At 5.5 years of age
Time frame: At 5.5 years of age
Time frame: At 5.5 years of age
Time frame: At 5.5 years of age
Time frame: At 5.5 year of age
Time frame: At 5.5 years of age
Mead Johnson Nutrition
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07565883
Cognitive Ability, General, Emotions
Salt Lake City, Utah, United States
View Trial DetailsNCT07048119
Behavior, Cognitive Ability, General
Santiago, Las Condes, Chile
View Trial DetailsNCT02843282
Bipolar Disorder, Bipolar and Related Disorders
View Trial DetailsNCT02726906
Aging, Alzheimer Disease
Los Angeles, California, United States
View Trial Details